title: Mitigation of Lethal Radiation Syndrome in Mice by Intramuscular Injection of 3D Cultured Adherent Human Placental Stromal Cells.
abstract: Exposure to high lethal dose of ionizing radiation results in acute radiation syndrome with deleterious systemic effects to different organs. A primary target is the highly sensitive bone marrow and the hematopoietic system. In the current study C3H/HeN mice were total body irradiated by 7.7 Gy. Twenty four hrs and 5 days after irradiation 2×10(6) cells from different preparations of human derived 3D expanded adherent placental stromal cells (PLX) were injected intramuscularly. Treatment with batches consisting of pure maternal cell preparations (PLX-Mat) increased the survival of the irradiated mice from ∼27% to 68% (P<0.001), while cell preparations with a mixture of maternal and fetal derived cells (PLX-RAD) increased the survival to ∼98% (P<0.0001). The dose modifying factor of this treatment for both 50% and 37% survival (DMF50 and DMF37) was∼1.23. Initiation of the more effective treatment with PLX-RAD injection could be delayed for up to 48 hrs after irradiation with similar effect. A delayed treatment by 72 hrs had lower, but still significantly effect (p<0.05). A faster recovery of the BM and improved reconstitution of all blood cell lineages in the PLX-RAD treated mice during the follow-up explains the increased survival of the cells treated irradiated mice. The number of CD45+/SCA1+ hematopoietic progenitor cells within the fast recovering population of nucleated BM cells in the irradiated mice was also elevated in the PLX-RAD treated mice. Our study suggests that IM treatment with PLX-RAD cells may serve as a highly effective "off the shelf" therapy to treat BM failure following total body exposure to high doses of radiation. The results suggest that similar treatments may be beneficial also for clinical conditions associated with severe BM aplasia and pancytopenia.
authors.affiliation: Sharett Institute of Oncology, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.
authors.forename: Elena
authors.initials: E
authors.lastname: Gaberman
authors.forename: Lena
authors.initials: L
authors.lastname: Pinzur
authors.forename: Lilia
authors.initials: L
authors.lastname: Levdansky
authors.forename: Maria
authors.initials: M
authors.lastname: Tsirlin
authors.forename: Nir
authors.initials: N
authors.lastname: Netzer
authors.forename: Zami
authors.initials: Z
authors.lastname: Aberman
authors.forename: Raphael
authors.initials: R
authors.lastname: Gorodetsky
mesh_terms: D000818:Animals; D002448:Cell Adhesion; D017690:Cell Transplantation; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D051379:Mice; D010920:Placenta / Q000166:cytology*; D011247:Pregnancy; D011832:Radiation Injuries / Q000628:therapy*; D017154:Stromal Cells / Q000166:cytology*; D014916:Whole-Body Irradiation